BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35331101)

  • 41. Inhibition of UFM1 expression suppresses cancer progression and is linked to the dismal prognosis and immune infiltration in oral squamous cell carcinoma.
    Ke D; Guo HH; Jiang N; Shi RS; Fan TY
    Aging (Albany NY); 2023 Nov; 15(22):13059-13076. PubMed ID: 37980168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
    Chi J; Liu Y; Yang L; Yang J
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma.
    Qiu B; Sun Y; Nie W; Yang Q; Guo X
    Immun Inflamm Dis; 2023 May; 11(5):e845. PubMed ID: 37249289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HMGB1-activated tumor-associated macrophages promote migration and invasion via NF-κB/IL-6 signaling in oral squamous cell carcinoma.
    Jiang M; Liu L; Huang W; Qi Y; Li Y; Li B
    Int Immunopharmacol; 2024 Jan; 126():111200. PubMed ID: 37988913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
    Wu R; Zuo W; Xu X; Bi L; Zhang C; Chen H; Liu H
    Biomed Res Int; 2021; 2021():6650791. PubMed ID: 34189138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
    Zheng S; Wu R; Deng Y; Zhang Q
    Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
    Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
    Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
    Shen Q; Xiong P; Yang D; Chen L
    Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
    Wang X; Zhang Y; Zhang S; Duan L
    Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lactic acid-induced M2-like macrophages facilitate tumor cell migration and invasion via the GPNMB/CD44 axis in oral squamous cell carcinoma.
    Lin Y; Qi Y; Jiang M; Huang W; Li B
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110972. PubMed ID: 37806107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
    Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
    Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma.
    Chen Q; Wang Y; Li F; Cheng X; Xiao Y; Chen S; Xiao B; Tao Z
    Anticancer Agents Med Chem; 2022; 22(6):1080-1090. PubMed ID: 34229595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.